Henan University of Traditional Chinese Medicine is the lead sponsor of 18 current clinical trials in our China register. 4 are recruiting patients now. The most common phase is Observational. The most-studied condition is Chronic Obstructive Pulmoriary Disease (COPD).
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Study on the Mechanism of Yifei Moxibustion Improving Immune Function in COPD Based on Plasma Exosome miRNAs
NCT07131020 · ClinicalTrials.gov ↗ · Stable COPD Patients
|
Not applicable | Recruiting | 2024-05 | China |
|
Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma
NCT07632352 · ClinicalTrials.gov ↗ · Bronchial Asthma
|
Not applicable | Recruiting | 2025-04 | China |
|
A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections
NCT07206745 · ClinicalTrials.gov ↗ · Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection
|
Not applicable | Recruiting | 2025-12 | China |
|
REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)
NCT06577753 · ClinicalTrials.gov ↗ · Interstitial Lung Disease
|
Observational | Recruiting | 2024-04 | China |
|
Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD)
NCT06577701 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmoriary Disease (COPD), Preserved Ratio Impaired Spirometry (PRISM)
|
Observational | Not yet open | 2024-10 | China |
|
Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine
NCT06613659 · ClinicalTrials.gov ↗ · Community-Acquired Infections
|
Observational | Not yet open | 2024-09 | China |
|
Systemic Traditional Chinese Medicine in Multidrug-Resistant Bacterial Pneumonia
NCT07726095 · ClinicalTrials.gov ↗ · Multi Drug Resistant Infections, Pneumnia
|
Observational | Not yet open | 2026-08 | China |
|
Disease-syndrome Characteristics of IPF
NCT07178392 · ClinicalTrials.gov ↗ · Idiopathic Pulmonary Fibrosis (IPF)
|
Observational | Not yet open | 2025-09 | China |
|
Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF
NCT06914713 · ClinicalTrials.gov ↗ · Idiopathic Pulmonary Fibrosis(IPF)
|
Not applicable | Not yet open | 2025-08 | China |
|
Screening for High-risk Chronic Obstructive Pulmonary Disease
NCT06350305 · ClinicalTrials.gov ↗ · High-risk COPD
|
Observational | Not yet open | 2024-05 | China |
|
Clinical Study on Improving Exercise Capacity in Chronic Obstructive Pulmonary Disease Through Smart IoT-Remote Home Breathing Guidance
NCT06963333 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease
|
Not applicable | Not yet open | 2025-06 | China |
|
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)
NCT06373692 · ClinicalTrials.gov ↗ · Bronchial Asthma
|
Observational | Not yet open | 2024-05 | China |
|
Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome
NCT07352488 · ClinicalTrials.gov ↗ · Allergic Asthma
|
Not applicable | Not yet open | 2026-01 | China |
|
The Severity Assessment Model for AECOPD With Combination of Disease and Syndrome
NCT06918353 · ClinicalTrials.gov ↗ · Acute Exacerbation of Chronic Obstructive Pulmonary Disease
|
Observational | Not yet open | 2025-04 | China |
|
TCM Cohort for Elderly COPD
NCT07780682 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease (COPD)
|
Observational | Not yet open | 2026-08 | China |
|
Idiopathic Pulmonary Fibrosis Cohort of TCM
NCT07162870 · ClinicalTrials.gov ↗ · Idiopathic Pulmonary Fibrosis (IPF)
|
Observational | Not yet open | 2025-09 | China |
|
Clinical Study on the Treatment of Chronic Airway Diseases (Asthma, Chronic Obstructive Pulmonary Disease) with Shu Fei Tie
NCT06691802 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmoriary Disease (COPD), Asthma
|
Not applicable | Not yet open | 2024-12 | China |
|
TCM Cohort for Elderly CAP
NCT07797686 · ClinicalTrials.gov ↗ · Community-acquired Pneumonia (CAP)
|
Observational | Not yet open | 2026-08 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 18 | 4 |
A trial with sites in more than one country appears in each of those registers.
Henan University of Traditional Chinese Medicine is the lead sponsor of 18 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.
Yes. 4 of its 18 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.